,for, Item ID-
  • #1180219
  • NanoEnTek USA Inc #FRCOD-020

Immunoassay Reagent Frend™ COVID-19 Total Ab SARS-CoV-2 Total For FREND System 20 Tests

CARTRIDGE, FREND SYS COVID-19 TOTAL ANTIBODY (20/KT) D/S

Features

  • The FREND™ COVID-19 total Ab assay is only for use under the Food and Drug Administration’s Emergency Use Authorization: https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-use-authorizations
  • Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C §263a, that meet requirements to perform moderate or high complexity tests
  • The FREND™ COVID-19 total Ab is a fluorescence immunoassay (FIA) using the FREND™ System intended for the qualitative detection of total antibody to SARS-CoV-2 in human dipotassium EDTA plasma
  • More …
  Log In to Order
or

Product Specifications


Features
  • The FREND™ COVID-19 total Ab assay is only for use under the Food and Drug Administration’s Emergency Use Authorization: https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-use-authorizations
  • Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C §263a, that meet requirements to perform moderate or high complexity tests
  • The FREND™ COVID-19 total Ab is a fluorescence immunoassay (FIA) using the FREND™ System intended for the qualitative detection of total antibody to SARS-CoV-2 in human dipotassium EDTA plasma
  • FREND™ COVID-19 total Ab is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection
  • At this time, it is unknown for how long antibodies persist following infection and if the presence of antibodies confers protective immunity; the FREND™ COVID-19 total Ab should not be used to diagnose acute SARSCoV-2 infection
  • Laboratories within the United States and its territories are required to report all results to the appropriate public health authorities
  • The sensitivity of FREND™ COVID-19 total Ab early after infection is unknown
  • Negative results do not preclude acute SARS-CoV-2 infection; if acute infection is suspected, direct testing for SARS-CoV2 is necessary
  • False positive results for FREND™ COVID-19 total Ab may occur due to cross-reactivity from preexisting antibodies or other possible causes
  • Due to the risk of false positive results, confirmation of positive results should be considered using second, different total antibody assay
  • Results can be obtained in less than 3 minutes with only 35 µl of sample volume using the FREND System
  • Kit includes: 20 cartridges, 20 dilution tubes, 40 disposable pipette tips, code chip, and package insert
  • The following materials are NOT provided with the reagent but are required to perform COVID-19 total antibody analysis using the FREND™ COVID-19 total Ab on the FREND™ System: FREND™ System including calibrated pipette and QC Cartridge and QC Code chip manufactured by NanoEntek
More Information

Frequently Viewed Together